Food and Drug Administration Modernization Act of 1997
E165705
The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Food and Drug Administration Modernization Act of 1997 canonical | 3 |
| FDA Modernization Act of 1997 | 1 |
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal statute
ⓘ
health law ⓘ |
| aimedAt |
enhancing patient access to experimental therapies
ⓘ
modernization of FDA ⓘ speeding approval of drugs ⓘ speeding approval of medical devices ⓘ streamlining FDA regulatory procedures ⓘ |
| amends | Federal Food, Drug, and Cosmetic Act ⓘ |
| appliesTo | Food and Drug Administration ⓘ |
| authorizes |
FDA to accept user fees for device review
ⓘ
FDA to rely on third-party review for some devices ⓘ dissemination of peer-reviewed journal articles on off-label uses under conditions ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| enactedBy | United States Congress ⓘ |
| establishes |
framework for risk-based regulation of devices
ⓘ
procedures for meetings and dispute resolution with FDA ⓘ requirements for clinical trial registration in certain contexts ⓘ |
| goal |
improve patient access to new therapies
ⓘ
maintain standards for safety and effectiveness ⓘ reduce regulatory burden on industry ⓘ |
| includes |
provisions on device tracking and postmarket surveillance
ⓘ
provisions on health claims for foods ⓘ provisions on pharmacy compounding ⓘ provisions on radiopharmaceuticals ⓘ |
| jurisdiction | federal regulation of food and drugs in the United States ⓘ |
| providesFor |
expanded access to investigational devices
ⓘ
expanded access to investigational drugs ⓘ fast track designation for certain drugs ⓘ postmarketing studies requirements ⓘ use of surrogate endpoints in approval ⓘ |
| regulates |
biological products approval
ⓘ
drug approval process ⓘ medical device approval process ⓘ |
| relatedTo |
Food and Drug Administration Safety and Innovation Act of 2012
ⓘ
surface form:
Food and Drug Administration Safety and Innovation Act
Prescription Drug User Fee Act of 1992 ⓘ
surface form:
Prescription Drug User Fee Act
|
| shortName | FDAMA ⓘ |
| signedBy | Bill Clinton ⓘ |
| signingPresident | Bill Clinton ⓘ |
| subject |
biologics regulation
ⓘ
clinical trials ⓘ drug regulation ⓘ fast track drug approval ⓘ medical device regulation ⓘ off-label information dissemination ⓘ pediatric studies of drugs ⓘ pharmacy compounding ⓘ user fees ⓘ |
| timePeriod | 1990s health policy reforms in the United States ⓘ |
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.
Federal Food, Drug, and Cosmetic Act
→
amendedBy
→
Food and Drug Administration Modernization Act of 1997
ⓘ
this entity surface form:
FDA Modernization Act of 1997
Prescription Drug User Fee Act of 1992
→
relatedTo
→
Food and Drug Administration Modernization Act of 1997
ⓘ